Related Experiment Video
Updated: May 23, 2026
05:14
Examination of Pyroptosis by Flow Cytometry
Published on: May 31, 2024
Pyroptosis, A Double-Edged Sword in Respiratory Diseases: A Narrative Review
Chen Yu1, Caijun Dai1, Lujian Zhu2
1Department of Respiratory and Critical Care Medicine, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, People's Republic of China.
Journal of Inflammation Research
|May 22, 2026
Summary
Pyroptosis, an inflammatory cell death, involves gasdermin proteins and is implicated in respiratory diseases. Understanding pyroptosis mechanisms and targeting its pathways offers potential for treating lung conditions.
Area of Science:
- Immunology
- Cell Biology
- Pathology
Background:
- Pyroptosis is a programmed cell death (PCD) pathway mediated by gasdermin proteins.
- It is triggered by danger signals and involves caspase activation, leading to membrane pore formation and cell lysis.
- Dysregulated pyroptosis contributes to inflammation and tissue damage, particularly in respiratory diseases.
Purpose of the Study:
- To review the molecular mechanisms and regulatory networks of pyroptosis.
- To explore the role of pyroptosis in various respiratory diseases, including infections, ALI/ARDS, asthma, COPD, PF, and lung cancer.
- To examine therapeutic strategies targeting pyroptotic pathways for respiratory immune-inflammatory diseases.
Main Methods:
- Literature review of pyroptosis mechanisms and its involvement in respiratory pathologies.
- Analysis of recent findings on gasdermin family roles in disease.
- Examination of current and emerging therapeutic strategies targeting pyroptosis.
Main Results:
- Pyroptosis acts as a double-edged sword in innate immunity, defending against pathogens but causing damage when dysregulated.
- Evidence links pyroptosis to pulmonary infections, ALI/ARDS, asthma, COPD, PF, and lung cancer.
- Targeting pyroptotic pathways shows promise for therapeutic intervention.
Conclusions:
- Pyroptosis plays a complex and often dual role in respiratory immune-inflammatory diseases.
- Further research into pyroptosis mechanisms and Gasdermin family functions is crucial.
- Targeted therapies for pyroptosis offer potential for clinical translation in treating lung diseases.
Related Concept Videos
01:08Pneumothorax II: Pathophysiology
Pneumothorax means the presence of air in the pleural space — the thin potential gap between the visceral and parietal pleura. This condition disrupts the normal pressure balance that keeps the lungs inflated, leading to partial or complete collapse of the affected lung.Normal physiologyUnder normal conditions, the pleural space maintains a slightly negative intrapleural pressure, which keeps the lungs expanded against the chest wall. This negative pressure creates a delicate balance between...
01:29Pneumonia II: Pathophysiology
The pathophysiology of pneumonia involves the following steps:
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:10Atelectasis II: Pathophysiology
Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through collapsed...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:29Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...